Novel delivery mechanisms for antigen-specific immunotherapy.

Current Opinion in Endocrinology, Diabetes, and Obesity
Tobias Neef, Stephen D Miller

Abstract

Current therapies for autoimmune disorders often employ broad suppression of the immune system. Antigen-specific immunotherapy (ASI) seeks to overcome the side-effects of immunosuppressive therapy by specifically targeting only disease-related autoreactive T and B cells. Although it has been in development for several decades, ASI still is not in use clinically to treat autoimmunity. Novel ways to deliver antigen may be effective in inducing ASI. Here we review recent innovations in antigen delivery. New ways to deliver antigen include particle and nonparticle approaches. One main focus has been the targeting of antigen-presenting cells in a tolerogenic context. This technique often results in the induction and/or expansion of regulatory T cells, which has the potential to be effective against a complex, polyclonal immune response. Whether novel delivery approaches can help bring ASI into general clinical use for therapy of autoimmune diseases remains to be seen. However, preclinical work and early results from clinical trials using these new techniques show promising signs.

References

Sep 24, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Valeria JudkowskiDarcy B Wilson
Dec 29, 2004·Journal of Drug Targeting·Paul R LockmanDavid D Allen
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Danielle M Turley, Stephen D Miller
Oct 10, 2008·The New England Journal of Medicine·Johnny LudvigssonRosaura Casas
Jun 29, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Mikael ChéramyRosaura Casas
Aug 9, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel R GettsStephen D Miller
Jun 7, 2013·Science Translational Medicine·Andreas LutterottiRoland Martin
Nov 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel R GettsStephen D Miller
Feb 8, 2014·Diabetes Management·Dan XuStephen D Miller
Mar 13, 2014·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Derrick P McCarthyStephen D Miller
Jul 10, 2014·Seminars in Immunopathology·Peter In't Veld
Feb 24, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Pau Serra, Pere Santamaria
Apr 7, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jamal S LewisBenjamin G Keselowsky
Jun 20, 2015·Trends in Immunology·Daniel R GettsNicholas J C King
Sep 26, 2015·Journal of Autoimmunity·James A PearsonLi Wen
Feb 18, 2016·Nature·Xavier Clemente-CasaresPere Santamaria
Oct 19, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Derrick P McCarthyLonnie D Shea
Apr 25, 2017·Nature Nanotechnology·Santiswarup SinghaPere Santamaria
Aug 10, 2017·Current Diabetes Reports·Tobias Neef, Stephen D Miller
Dec 21, 2017·Journal of Autoimmunity·Suchitra PrasadStephen D Miller
Dec 12, 2018·The Lancet. Diabetes & Endocrinology·Bart O RoepMark Peakman
Dec 27, 2018·Journal of Proteome Research·T. Aaron WilesThomas Delong
Feb 26, 2019·Nature Biotechnology·Pau Serra, Pere Santamaria
Mar 27, 2019·International Journal of Pharmaceutics·M DulUNKNOWN EE-ASI Consortium
Apr 10, 2019·Proceedings of the National Academy of Sciences of the United States of America·Irati ZubizarretaPablo Villoslada
May 16, 2019·Nature Communications·Channakeshava Sokke UmeshappaPere Santamaria
May 22, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Braxton L JamisonKathryn Haskins
Jun 9, 2019·Diabetes·Rocky L BakerThomas Delong
Sep 3, 2019·Current Opinion in Immunology·Lawrence SteinmanPablo Villoslada
Dec 20, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Adrian VillalbaMarta Vives-Pi
Dec 25, 2019·Molecular Therapy. Methods & Clinical Development·Rebuma Firdessa-Fite, Rémi J Creusot
Feb 8, 2020·Gastroenterology·Tobias L FreitagDaniel R Getts
Feb 23, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Farah ArikatJames C Birchall
Mar 4, 2020·The Journal of Clinical Investigation·Channakeshava Sokke UmeshappaPere Santamaria

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Kazim SahinJames R Komorowski
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
H J Schmoll
© 2021 Meta ULC. All rights reserved